Pictet Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Pictet Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,000	Closed	-$223K	–	88
2017 Q2	$223K	Hold	4,000	–	–	0.07%	93
2017 Q1	$218K	Hold	4,000	–	–	0.06%	80
2016 Q4	$234K	Hold	4,000	–	–	0.08%	77
2016 Q3	$216K	Hold	4,000	–	–	0.07%	79
2016 Q2	$294K	Hold	4,000	–	–	0.11%	64
2016 Q1	$256K	Hold	4,000	–	–	0.09%	79
2015 Q4	$275K	Sell	4,000 -8,400	-68%	-$555K	0.1%	70
2015 Q3	$734K	Hold	12,400	–	–	0.26%	48
2015 Q2	$825K	Buy	12,400 +8,400	+210%	+$554K	0.28%	44
2015 Q1	$258K	Hold	4,000	–	–	0.1%	66
2014 Q4	$236K	Hold	4,000	–	–	0.09%	85
2014 Q3	$205K	Buy	+4,000	New	+$200K	0.08%	96
2014 Q2	–	Sell	-4,000	Closed	-$208K	–	99
2014 Q1	$208K	Hold	4,000	–	–	0.08%	83
2013 Q4	$213K	Buy	+4,000	New	+$204K	0.09%	78

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pictet Bank & Trust's BMY Position: Q3 2017 in Review

Pictet Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 4,000 shares — an estimated $223K sold.

Pictet Bank & Trust first reported a position in BMY in Q4 2013 and held it in 14 quarters. The position peaked at $825K in Q2 2015. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Pictet Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
Pictet Bank & Trust sold 4,000 Bristol-Myers Squibb shares in Q3 2017, an estimated $223K.
Pictet Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 14 quarters.
Pictet Bank & Trust's Bristol-Myers Squibb position peaked at $825K in Q2 2015.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Pictet Bank & Trust's 13F filing for Q3 2017, filed 7 Nov 2017.